Prevention of Infection
AssigneePop Test Cortisol LLC
InventorsRandice Lisa Altschul, Neil David Theise, Myron Rapkin, Rebecca O'Brien
Life of this patent
Estimating the term…
Abstract
The invention relates to compounds and methods for the prevention and/or treatment of infection after stroke.
Claims15
A method for treating or preventing infection after ischemic stroke wherein said method comprises administering to a patient in need of such therapy at least one glucocorticoid receptor antagonist in a therapeutically effective amount.
A method of treating or preventing infection secondary to CNS injury in a patient in need thereof, comprising administering at least one GCR antagonist in a therapeutically effective amount.
A kit for treating or preventing infection after ischemic stroke comprising:
- (a) a pharmaceutical composition comprising at least one glucocorticoid receptor antagonist in a therapeutically effective amount;
- and
- (b) at least one blister package;
- a lidded blister;
- a blister card or packet;
- a clamshell;
- an intravenous (IV) package, IV packette or IV container;
- a tray or a shrink wrap comprising the pharmaceutical composition of (a) and instructions for use of the pharmaceutical composition for treating or preventing infection after ischemic stroke.
A product of manufacture for treating or preventing infection after ischemic stroke comprising a blister package;
- a lidded blister;
- a blister card or packet;
- a clamshell;
- an intravenous (IV) package, IV packette or IV container;
- a tray or a shrink wrap comprising a pharmaceutical composition comprising at least one glucocorticoid receptor antagonist, and instructions for use of the pharmaceutical composition for treating or preventing infection after ischemic stroke.
A method for reducing infarct severity and improving long term outcome after ischemic stroke wherein said method comprises administering, to a patient in need of such therapy, at least one glucocorticoid receptor antagonist in a therapeutically effective amount.
A method of treating or preventing infection secondary to CNS injury in a patient in need thereof, comprising administering at least one GCR antagonist in a therapeutically effective amount.
A method for improving long term outcome secondary to CNS injury in a patient in need thereof, comprising administering at least one GCR antagonist.
A kit for reducing infarct severity and improving long term outcome after ischemic stroke comprising:
- (a) a pharmaceutical composition comprising at least one GCR antagonist;
- and
- (b) at least one blister package;
- a lidded blister;
- a blister card or packet;
- a clamshell;
- an intravenous (IV) package, IV packette or IV container;
- a tray or a shrink wrap comprising the pharmaceutical composition of (a) and instructions for use of the pharmaceutical composition for treating or preventing infection after ischemic stroke.
A product of manufacture for reducing infarct severity and improving long term outcome after ischemic stroke comprising a blister package;
- a lidded blister;
- a blister card or packet;
- a clamshell;
- an intravenous (IV) package, IV packette or IV container;
- a tray or a shrink wrap comprising a pharmaceutical composition comprising at least one glucocorticoid receptor antagonist, and instructions for use of the pharmaceutical composition for treating or preventing infection after ischemic stroke.
Dependencies are inferred from the claim text.